Rajendrakumar H. Jani

533 citations
8 papers · 422 indexed · h-index 7

Rajendrakumar H. Jani

8 papers receiving 404 citations

Peers

Rajendrakumar H. Jani
Comparison fields: 5 of 71
  • Endocrinology, Diabetes and Metabolism 134
  • Microbiology 40
  • Hepatology 29
  • Food Science 54
  • Molecular Biology 193
Replace Yoko Tokunaga with:
Yoko Tokunaga Japan
Tsunemichi Hosokawa Japan
Shuying S. Li United States
Miriam Barbanti Italy
Hiromi Sakamoto Japan
H. Hattori Japan
Lihua Wu China
Witaya Thamavit Thailand
Albert Théophane Yonli Burkina Faso
Thomas S. Frank United States
Rajendrakumar H. Jani relative to Yoko Tokunaga Japan Yoko Tokunaga's profile →
Citations per field
00.5×1.5×2.1×
Yoko Tokunaga · 1×
Citations per year

Countries citing papers authored by Rajendrakumar H. Jani

Since Specialization
Citations

This map shows the geographic impact of Rajendrakumar H. Jani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajendrakumar H. Jani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajendrakumar H. Jani more than expected).

Fields of papers citing papers by Rajendrakumar H. Jani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajendrakumar H. Jani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajendrakumar H. Jani. The network helps show where Rajendrakumar H. Jani may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rajendrakumar H. Jani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rajendrakumar H. Jani Line = papers co-authored together Rajendrakumar H. Jani links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1 201732
2 20168
3 201552
4 201483
5 201349
6 201386
7
Comparative chemotherapeutic efficacy of balhimycin, desgluco-balhimycin against experimental MSSA and MRSA infection in mice.
20002
8 1992110

About Rajendrakumar H. Jani

Rajendrakumar H. Jani is a scholar working on Microbiology, Endocrinology, Diabetes and Metabolism and Emergency Medicine, having authored 8 papers that have together received 422 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Diabetes Treatment and Management (2 papers), Antimicrobial Peptides and Activities (2 papers), Cancer therapeutics and mechanisms (1 paper), Biochemical and Structural Characterization (1 paper), Microbial Natural Products and Biosynthesis (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (134 citations), Microbiology (40 citations) and Hepatology (29 citations). Rajendrakumar H. Jani has collaborated with scholars based in India, Australia and France. Frequent co-authors include Shashank Joshi, Satinath Mukhopadhyay, Anil Bhansali, Gerhard Seibert, B. N. GANGULI, N. Klesel, Kevinkumar Kansagra, Mukul R. Jain, J. BLUMBACH and Harilal Patel.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026